Study shows potential harms of BP drugs for low-risk, mild hypertension

Patients were excluded if they had previous blood pressure treatment before the study, or if they had a history of CVD, atrial fibrillation, diabetes or chronic kidney disease. Thus, the included patients fit the researchers’ standard for low-risk patients, which is an important distinction from previous studies—including the SPRINT trial which factored in to the new American guidelines.

“Although this trial (SPRINT) included a large number of people with mild hypertension at recruitment, all participants were considered to be at high risk of CVD and 90% were already undergoing treatment,” the authors noted.

Leave a Reply

Your email address will not be published. Required fields are marked *